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The gut microbiota codevelops with the immune system beginning at birth. Mining the microbiota for bacte-
rial strains responsible for shaping the structure and dynamic operations of the innate and adaptive arms of
the immune system represents a formidable combinatorial problem but one that needs to be overcome to
advance mechanistic understanding of microbial community and immune system coregulation and to
develop new diagnostic and therapeutic approaches that promote health. Here, we discuss a scalable,
less biased approach for identifying effector strains in complex microbial communities that impact immune
function. The approach begins by identifying uncultured human fecal microbiota samples that transmit
immune phenotypes to germ-free mice. Clonally arrayed sequenced collections of bacterial strains are con-
structed from representative donor microbiota. If the collection transmits phenotypes, effector strains are
identified by testing randomly generated subsets with overlapping membership in individually housed
germ-free animals. Detailed mechanistic studies of effector strain-host interactions can then be performed.Introduction
First the good news: myriad aspects of host physiology, meta-
bolism, and immunity are being linked to the human gut
microbiota. Now the disconcerting news: one of the biggest
challenges for current research in this area is how to move
from observational studies where the configuration of a person’s
microbiota is correlated with their health status to mechanistic
studies that dissect how organisms impact host biology and
how we might take advantage of the knowledge gained to
develop new medical treatments.
Our adult intestines harbor a microbiota composed of tens of
trillions of microbes representing all three domains of life (and
their viruses); most belong to the domain Bacteria. Current
evidence from studies of healthy adults living in the USA or Eu-
rope is that we harbor roughly 100 species of gut bacteria,
various combinations of which could be responsible for various
functions and effects (Qin et al., 2010; Faith et al., 2013). This
means that we have an immense combinatorial problem—
namely, how to efficiently search the vast number of possible
species combinations to find those ‘‘effector strains’’ that indi-
vidually or in concert affect one or more of our biological fea-
tures. The lack of unbiased methods to identify the contributions
of various community members to different human phenotypes
has hampered efforts to harness the diagnostic potential of the
microbiota. These effector strains also represent the starting
point for discovery and development programs designed to
identify next-generation probiotics for new types of microbiota-
directed therapeutics, including but not limited to those involving
various aspects of immune function.
Previous Approaches for Identification of Effector
Bacterial Strains
A widely practiced approach for identifying effector strains has
been to employ culture-independent, DNA sequence-basedmethods to compare the abundance of bacterial taxa in gut
microbiota associatedwith a given host phenotype to their abun-
dance in communities where this phenotype is quantitatively or
qualitatively different. This search is less daunting in mouse
models because host genetic and environmental factors can
be constrained in ways that are not practically or ethically
feasible in human populations. The hope is that what is found
in the animal models will be translatable to humans.
A ‘‘classic’’ illustration of this approach involves segmented
filamentous bacteria (SFB) and its discovery as an effector of
intestinal T helper 17 (Th17) cell responses. Comparing the
gut (ileal) microbiota of conventionally-raised C57BL/6 mice
from Jackson Laboratory that lack Th17 cells in their small in-
testinal lamina propria to the gut microbiota of C57BL/6 mice
from Taconic Farms that have abundant Th17 cells in this
compartment (Ivanov et al., 2008), revealed two bacterial taxa
that were significantly enriched (>25 fold) in mice originating
from Taconic Farms (Ivanov et al., 2009). One was SFB, which
was subsequently shown to be sufficient in of itself for Th17 cell
induction (Ivanov et al., 2009; Gaboriau-Routhiau et al., 2009).
Unfortunately, such clean-cut examples are rare. Add in
another fact of life: differences in abundance alone might not
be the best metric to use when searching for members of a
gut microbial community that are causally related to an immune
phenotype. For example, Bloom and colleagues used a mouse
model of inflammatory bowel disease (IBD) where signaling of
the anti-inflammatory cytokines transforming growth factor b
(TGF-b) and interleukin-10 (IL-10) was abrogated to show that
Bacteroides thetaiotaomicron was causally related to severe in-
testinal pathology even though its relative abundance in the mi-
crobiota was not significantly different in inflammatory versus
noninflammatory states. In contrast, E. coli, which was en-
riched under inflammatory conditions, lacked colitogenic activ-
ity (Bloom et al., 2011). In another model of IBD involvingImmunity 40, June 19, 2014 ª2014 Elsevier Inc. 815
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ella pneumoniae and Proteus mirabilis were associated with
inflammation but insufficient to produce disease when trans-
ferred to germ-free recipients. However, they were pathogenic
when added to specific pathogen-free (SPF) mice with already
established gut communities (Garrett et al., 2010).
The Challenge of Looking Beyond Species-Level
Diversity to Strain-Level Diversity
Another challenge is that we need to look beyond (bacterial)
species-level diversity and consider that different strains of a
given species-level phylogenetic type might have considerably
different biological effects. This strain level diversity exists within
individuals. Until recently, it has been difficult to reliably assign
strain-level designations to bacterial members of the microbiota
with high-throughput DNA sequencing methods that focus on
amplicons generated from the phylogenetic marker gene encod-
ing the principal RNA molecule in the small ribosomal subunit
(16S rRNA). However, as noted below this problem is being over-
come with new low-error amplicon-sequencing techniques
(Faith et al., 2013).
Recent studies emphasize the importance of considering
strain-level differences. For example, analysis of Il10/ mice
treated with the alkylating mutagen azoxymethane (AOM)
revealed that E. coli strains possessing the polyketide synthase
(pks) genotoxic island that elicit DNA damage in cultured intes-
tinal epithelial cells, promote tumorigenesis in the colon.
Neither a naturally occurring pks-minus strain of E. coli, nor
one with an engineered deletion of pks elicited DNA damage
in vitro to an extent equivalent to that of the pks-positive
strain. Moreover, AOM-treated Il10/ recipients of the deletion
mutant displayed reduced tumor multiplicity and invasion rela-
tive to recipients of the pks-positive strain (Arthur et al., 2012).
In multiple intestinal neoplasia (Min) mice heterozygous for a
null allele of the Apc gene, a B. fragilis strain expressing the toxin
BFT produced colitis, whereas strains lacking the toxin did not
(Wu et al., 2009). These findings suggest that surveying bacterial
isolates from gut microbiota samples obtained from an individual
with a given immune phenotype, rather than ‘‘domesticated’’
strains of the same species that are available as ‘‘off the shelf’’
reagents from existing culture repositories, might be a more
informative way for identifying effector strains and characterizing
the nature of their interactions with a host.
The Challenge of Capturing the Bacterial Diversity
Present in the Gut in Culture
Other challenges need to be added to the list. A number of labs
have worked to improve our ability to culture the range of
bacterial diversity present in the human gut microbiota. This
cultured diversity can be quantified either in terms of community
membership (e.g., 50 out of 100 total strains) or proportionally
weighted by the abundance of each microbe (e.g., 80% of the
sequenced microbiota). Using a single rich medium and anaer-
obic growth conditions, approximately 50% of the bacterial spe-
cies-level taxonomic diversity (97% ID OTUs) and 60% of the
proportionally weighted genus-level diversity present in previ-
ously frozen fecal samples can be captured in clonally arrayed
culture collections generated by limiting dilution in multiwell
format or by direct plating (Goodman et al., 2011; Ridaura816 Immunity 40, June 19, 2014 ª2014 Elsevier Inc.et al., 2013; Faith et al., 2013). This approach allows a collection
of bacterial strains that have coexisted and coevolved in an indi-
vidual’s gut to be recovered, archived, and characterized in vitro
and/or in vivo. Lagier et al. (2012) tested 212 different culture
conditions and identified 20 different types of media that were
sufficient to isolate over 70%of the bacterial strain-level diversity
present across three individuals. Nonetheless, much work re-
mains to be done to further expand our ability to culture previ-
ously unculturable microbes that inhabit this ecosystem.
Applying high-fidelity, low-error 16S rRNA amplicon-
sequencingmethods (e.g., LEA-Seq) tomicrobiotasamples (Faith
et al., 2013) enables more precise quantification of the efficiency
of isolation at the strain-level. This capacity enablesmedia condi-
tions to beoptimized so that the largest proportionof amicrobiota
can recovered with a minimized number of culture conditions.
Using the 16S rRNA gene to confidently identify strain-
level variants of a given species requires a high degree
of sequencing accuracy. This can be achieved with redundant
sequencing of the DNA template. The goal is to generate fewer
molecules to be sequenced than the available sequencing
depth. For example, if the aim is to sequence 1,000,000 mole-
cules in a sample, by starting with only 10,000 molecules of
template you have the potential to sequence each template,
or at least a copy of each template, up to 100 times. This
redundancy enables error correction of the resultant reads
because multiple sequences from each template DNA molecule
allow removal of errors as long as the sequencing technology is
unbiased in its error profile and generates true nucleotides
more often than erroneous ones. This reduction in the number
of template molecules relative to the sequencing capacity is the
opposite of what is done in most sequencing contexts where a
vast excess of template molecules are present and a subset
are sequenced. To create a finite DNA pool that is smaller
than the amount of sequencing effort applied (that is, to create
a bottleneck), a method for labeling the molecules in the pool
is needed. One approach for redundantly sequencing PCR
amplicons is to dilute the initial template DNA to create a
bottleneck. However, this dilution would need to be determined
for every input sample. In LEA-Seq, a bottleneck is created with
a linear PCR extension of the template amplicon using a dilute
barcoded oligonucleotide primer solution. Each oligonucleotide
is labeled with a random barcode, 50 to the universal 16S rRNA
primer sequence. The complexity of barcodes is far greater
than the number of unique amplicons to be sequenced, thus
ensuring that having the same barcode attached to multiple
amplicons is an extremely improbable event. Another feature
of the primer design is placement of a short adaptor sequence
at its 50 end that contains a fragment of the sequencing primer
needed for the DNA sequencing platform of choice. Placing this
or any adaptor region on the 50 end enables unique amplifica-
tion of the linear PCR without the need to remove existing tem-
plate DNA to or purify the linear primer. This feature enables an
‘‘add-only’’ reaction with few steps, and facilitating automation.
The Challenge of Improving the ‘‘Throughput’’ for
Functional Analyses of Microbial Consortia in
Gnotobiotic Mice
Another obstacle that stands squarely in the path of systematic
dissection of the contributions of gut microbial community
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ments are currently performed (Faith et al., 2010). The develop-
ment of gnotobiotic animal models has enabled the effects of
individual microbial species or strains or consortia composed
of defined collections of organisms recovered from a human
gut microbiota to be assayed. Traditionally, germ-free animals
are housed inside a gnotobiotic isolator; controlled entry of
sterilized food, water, bedding, and other consumables allows
experimenters to maintain animals under germ-free conditions
until such time as they are colonized (‘‘gnotobiotic’’ is derived
from the Greek ‘‘gnosis,’’ meaning known, and ‘‘bios,’’ meaning
life). Although many cages can be housed inside one large
gnotobiotic isolator, it is virtually impossible to maintain multi-
ple cages, each containing mice harboring different microbial
communities, in the isolator without cross-cage contamination.
Therefore, testing large numbers of communities is impractical
given the large number of gnotobiotic isolators that would be
required.
Past Successes in Identifying Bacterial Strains that
Modulate Regulatory T Cells
Despite these challenges, researchers have succeeded in
identifying bacterial species that modulate immune responses.
One key area where great success has been achieved is in
examining effects on regulatory T cells. Germ-free mice have
a paucity of Tregs in their colonic lamina propria compared to
mice harboring a gut microbiota (Atarashi et al., 2013; Atarashi
et al., 2011; Geuking et al., 2011; Weiss et al., 2012). Thus,
the expansion of the colonic Treg compartment and the induc-
tion of peripheral Tregs (pTregs) in the colon (Atarashi et al.,
2013; Atarashi et al., 2011; Geuking et al., 2011; Lathrop
et al., 2011; Round and Mazmanian, 2010; Weiss et al., 2012),
represents an attractive model for assessing how gut bacteria
invoke tolerance to foreign antigens; the results have therapeu-
tic relevance given the role of pTreg in preventing inflammation
(Bilate and Lafaille, 2011; Curotto de Lafaille and Lafaille, 2009;
Haribhai et al., 2009; Haribhai et al., 2011; Mucida et al., 2005).
One approach used to identify these effector strains has been
to fractionate microbial communities to reduce the diversity
of potential candidates that mediate an immune phenotype.
In an elegant set of studies, Atarashi and colleagues used
chloroform-treated fecal microbiota from mice (Atarashi et al.,
2011) or a human donor (Atarashi et al., 2013) to enrich for
spore-forming bacteria that survive this harsh treatment. This
allowed isolation of a collection of chloroform-resistant Clostri-
dia strains that boosted colonic Treg cell generation and/or sup-
pressive function and promoted pTreg cell accumulation in
gnotobiotic mice. Nonetheless, approaches that selectively kill
particular subsets of bacteria, including those that use narrow-
spectrum antibiotics (Ivanov et al., 2008; Atarashi et al., 2011),
are biased and impede characterization of immune phenotypes
that require the concerted action of bacterial strains with very
different phylogenetic, physical, physiologic, and/or metabolic
properties.
A Path Forward for Overcoming the Combinatorial
Challenge in Identifying Effector Strains
Although the picture we have painted appears intimidating,
newer methods will help overcome these obstacles. While nosingle approach is devoid of limitations, the one outlined below
should help advance studies aimed at understanding the inter-
play between microbes and the immune system.
Exhaustively testing all combinations of microbes (bacteria)
for their ability to modulate a given phenotype requires testing
an inordinate number of combinations—requiring more than a
thousand, million, and billion combinations of strains, even for
smaller communities of 10, 20, and 30 strains, respectively.
Thus, a brute-force approach is not feasible. Heuristic ap-
proaches are needed to more efficiently sort through this
complexity. Given that many microbe-driven immune pheno-
types are likely to be partially additive and involve no more
than a few higher-order interactions (i.e., situations where two
or more specific microbes must be present to elicit a response),
this complexity can be reduced dramatically (Box et al., 2005;
Hastie et al., 2009).
Figure 1 describes an approach for tackling the combinatorial
challenge faced by microbiota researchers. The initial step is to
transplant intact uncultured human gut (fecal) microbiota sam-
ples representing different donor physiologic or disease states,
lifestyles, or geographies of interest, into germ-free mice. These
screens test the ability of donor microbiota to transmit a whole
range of phenotypes to recipient animals, from effects on meta-
bolism to modulating immune function. By screening multiple
donors, it is possible to ascertain whether the responses of
gnotobiotic transplant recipients occur with all or a majority of
tested microbiota or are highly donor-specific (Figure 1A). The
information gleaned is then used to identify microbiota samples
that induce a response that is representative of the donor popu-
lation or subpopulations.
The second step is to determine whether the culturable
component of a representative microbiota sample can transmit
the phenotype or phenotypes observed with the intact uncul-
tured sample (Figure 1B). A system for generating arrayed
collections of cultured anaerobic bacterial members of a human
gut microbiota sample in multiwell plates has been described
(Goodman et al., 2011). Based on Poisson distribution, a dilution
of the sample is selected so that there is 95% probability that if
growth is observed in a given well of the multiwell plate, then
that well will be monoclonal (i.e., growth derives from a single
starting bacterial cell). In general, this means that the dilution
will yield growth in one third of the wells. The resulting library
of primary isolates is then ‘‘compressed’’ robotically so that de-
rivative multiwell plates are constructed where each well con-
tains a cultured strain. The identity of each isolate in the clonally
arrayed library is then determined by first sequencing its 16S
rRNA gene and then its whole genome. In principle, altering
the dilution used to generate the initial library to increase the
number of starting cells in each well from one to two provides
a way to increase the yield of culturable organisms, because
those strains that have obligate nutrient sharing (syntrophic)
relationships with other strains might survive together, whereas
in the absence of the partner, neither is culturable (the ‘‘cost’’
of this approach is that simultaneous shotgun sequencing
of the genomes of the two organisms that occupy a given
well requires the ability to accurately assemble each strain’s
genome). Whereas the majority of culturing efforts have focused
on aerobic, microaerophilic, or anaerobic bacteria, analogous
strategies could be used to recover members of other domainsImmunity 40, June 19, 2014 ª2014 Elsevier Inc. 817
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Figure 1. An Experimental Pipeline for Dissecting the Interactions of Effector Strains Present in Complex Microbial Communities with the
Host Immune System
(A) The first step involves transplanting intact uncultured fecal microbiota from human donors to test the capacity of their gut microbial communities to impact
immune phenotypes in recipient germ-freemice. In the case shown, the effects of different donor microbiota on the percent representation of an immune cell type
of interest within a population of immune cells recovered from recipient gnotobiotic mice is plotted. Note that in principle, the approach can be applied to any
phenotype of interest.
(B) A representative human donor microbiota, nominated from the initial screen, is used to prepare a clonally arrayed culture collection in amultiwell plate, and the
genome of each cultured member is sequenced. Subsets of members of this community are generated: subsets are either rationally designed or cultured strains
are randomly assigned to subsets. Subsets (defined consortia) are then administered to recipient gnotobiotic mice.
(C) The order the subsets are introduced into different mice is randomized to minimize batch effects and biases, and the phenotype of interest is assayed.
(D) Sorting the tested subsets by their size (i.e., the total number of strains in the subset) enables estimation of the phenotype’s saturation point, if there is one. In
the situation depicted, one can begin to observe phenotype saturation with subset sizes of three, while higher variation is observed in community sizes smaller
than this. Therefore, using mice that are mono- or bicolonized would be an effective strategy for identifying which strains modulate this phenotype.
(E) In caseswhere fewmembers contribute to the phenotypic variation, effector strains can be identified by sorting the subsets based on the presence or absence
of each strain individually, with p values determined with a t test. In the example shown, strains A, C, and E have little effect on the phenotype being measured
whether they are present or absent, whereas strains B and D are present in most cases where the phenotype is observed.
(F) More complex interactions involving multiple effector strains can be more accurately inferred with model-based approaches that consider the combined
influence of all community members on the phenotype. In the example shown, feature selection can be used to demonstrate that the phenotype is manifest in
cases where strain B or D are present and absent in all cases where B and D are absent, thus identifying the strains B or D as key effector strains for this
phenotype. In E and F, the central horizontal bars show the mean value and the error bars represent the SEM. Each point represents a hypothetical response
measured in an individual recipient mouse.
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Figure 2. Outline of How Random Subsetting Can Identify
Immunogenic Effector Strains in a Hypothetical Gut Community
Composed of 25 Members
The figure shows hypothetical results of the induction of an immune cell type
being studied, in order to illustrate the process by which random subsetting of
clonally arrayed collections of cultured bacteria can be used to identify effector
strains.
(A) If all or manymembers of a community are capable of eliciting a phenotype,
then recipients of all subset sizes will manifest the response. Despite each
subset having different composition, no information is gained as to which
strains are responsible, because there is low variation in the response and it
already saturates at subset sizes as low as five bacteria (see text for further
discussion of saturation).
(B) If the ability to modify a phenotype is rare or restricted to just a single
community member, then the value of the approach becomes evident. In the
graph, there is a bimodal distribution in the response. By comparing the
membership of consortia that promote induction of a population of interest to
those that completely lack such populations, one can obtain a catalog of all
strains that are (1) always present when the response is observed and (2)
always absent when the response is not manifest. In the example shown in
(B), although many communities elicit induction of the immune cell population
of interest, there is only one effector strain common to all subsets. Followup
colonizations with reduced size subsets can be used to confirm that the
approach has indeed identified the correct effector strain and whether addi-
tional membership explains the capacity of a strain to imprint the phenotype.
Horizontal lines represent mean values; each point depicts the immune cell
response in an individual recipient mouse.
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Perspectiveof life represented in the microbiota to assess their contributions
to host biology.
Having a clonally arrayed library of cultured bacterial isolates
that have coevolved together in a given donor’s gut sets the
stage for selecting subsets of the collection for testing in gnoto-
biotic mice. An empirical approach is utilized that allows identifi-
cation of the size of consortia derived from a culture collection
that are capable of generating high variation in a host phenotype
of interest. This process involves a number of steps. First, sub-
sets of a nominal size (e.g., 3, 5, 10members, etc.) are generated(Figure 1B). Each subset of a given size represents a community
of unique composition but with overlapping membership. Sec-
ond, each of these communities is introduced into a germ-free
recipient mouse, with those harboring each subset housed
separately (see below). The phenotype of interest is then
measured in recipient mice after a defined period of time has
elapsed following oral gavage of the consortia (Figure 1C).
Both the composition of each subset of bacterial strains and
the order in which the subsets are tested are randomized tomini-
mize biases from strain selection and batch effects. Biological
repetition for each bacterial strain is obtained because subsets
have overlapping membership. Strains whose presence in a
community best explain the observed phenotypic variation are
identified (i.e., those strains that are common to subsets capable
of inducing the phenotypic response) and these are then
advanced to a validation stepwhere they alone or in combination
with other microbes, whose presence is necessary for the
phenotype to manifest, are introduced into germ-free recipients.
A key element in these approaches is the concept of pheno-
type saturation, which refers to the situation where multiple
strains individually or in concert can induce a response such
that the addition of more effector bacterial strains no longer
alters the response (Figure 1D). To identify potential effector
strains, there must be biological variation in the phenotype
across the tested subsets. If all tested subsets of given size
induce the phenotype relative to a germ-free control, and no sub-
set induces a response significantly greater than any other, then
the only information gained from each subset is that its evoked
host response differs from what is observed in a germ-free
mouse. However, if some subsets induce a response and others
do not, or if some subsets induce a more intense response than
others, then it is possible to use strain membership between
subsets to identify modulators (effectors) of the phenotype
(Figure 1E). The number of subsets tested and subset size
need to be determined empirically for each phenotype and will
depend on the number of effector strains for the phenotype
and the saturation profile. A good initial starting point is to first
test the extremes, because large subsets and the complete
cultured community will determine whether the effector strains
are in the culture collection, whereas smaller communities (<4
strains) will identify whether the phenotype can be saturated
by a large proportion of the community members.
A Conceptual Illustration of the Approach
This approach can be illustrated by considering an imagined
example where differentiation of an immune cell population of in-
terest occurs upon colonization with a 25-member community. If
we imagine a situation where all microbes present in this com-
munity could induce these cells, then regardless of subset
size, no variation will be observed and increased numbers of
immune cells will be seen in recipients of all communities
(Figure 2A). Thus, although community composition will be
different across many subsets, this cannot be linked to variation
in the response itself, and no information can be gleaned from
the study other than the fact that a large proportion of the com-
munity (perhaps all members) can elicit the response. If we now
consider that the response is driven by a single strain and that no
other members of the culture collection possess this capacity,
we will observe a different pattern. The only mice that shouldImmunity 40, June 19, 2014 ª2014 Elsevier Inc. 819
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of a subset containing this unique effector strain; significant vari-
ation will be evident in the cellular response of recipient mice
because the bacterial strain will not be present in every subset
(recall that strain distribution among the subsets is random).
From a probabilistic point of view, as community subset size is
altered, variation in response among gnotobiotic recipients will
change; e.g., the more members present in a given subset, the
greater the likelihood that any one particular member, such as
the hypothetical unique effector strain, will be present
(Figure 2B). Variation will be at its highest when 50% of the com-
munity is present, because half of the subsets will contain the
effector strain while half will not. Smaller subset sizes will have
lower variation because most gnotobiotic recipients will lack
the effector strain and thus lack the immune cells being studied.
Larger subset sizeswill have lower variation becausemost recip-
ients will contain the effector strain and thus induction of the im-
mune cell type will be observed. One can then compare the
membership of subsets across all recipients where induction
has or has not been observed and look for strains whose pres-
ence correlates significantly with the response. In cases where
the number of effector strains is small relative to the total number
of strains in the cultured community (i.e., effector strains << total
strains), the significance of such a result can be estimated with a
t test comparing immune cell number when the candidate
effector strain is absent versus when it is present. Applying this
absent versus present t test-based approach to each strain in
a culture collection provides an easy first-pass method to iden-
tify effector strains, although application of this method or any
of the model-based approaches discussed below is more likely
to be successful if data collected for subsets larger than the satu-
ration point are removed (Figures 1D and 1E). More complex sit-
uations can be envisioned where a small proportion of commu-
nity members (greater than 1) can elicit a response, or where
the combined activity of a few community members is required.
The experimental approach described above can be used to
identify such relationships but more complex model-based ana-
lyses need to be employed. One advantage of the model-based
approach is that it can simultaneously consider the contributions
of all strains in the culture collection and will therefore better
explain the observed variation when multiple strains contribute
to the phenotypic response (Figure 1F). In addition, there is a
wealth of existing modeling tools designed to identify interac-
tions between variables and other nonlinearities (e.g., if the
immune cell type is induced only with strainA AND strainB). A
category of modeling termed feature selection provides a
rigorous means to identify strains whose presence best explains
the observed phenotypic variation. Feature selection tools
include stepwise regression, lasso (Efron et al., 2004), and
random forests (Breiman, 2001). These techniques search the
model variables for the subset that explains the most variation.
One of the simplest and most common algorithms is stepwise
regression with forward selection, where the variables are added
to the model one-at-a-time, always adding the variable that im-
proves the model the most until including additional variables
does not improve the model above a predefined limit. Feature
selection techniques can be run on thousands of response
variables to identify those best explained by microbiota compo-
sition, as is the case for assays like RNA-seq and metabolomics820 Immunity 40, June 19, 2014 ª2014 Elsevier Inc.that measure numerous responses in parallel. Such approaches
are also likely to be of benefit when multiple features of a given
host response are being tested. For example, the immune cell
population of interest might be heterogenous expressing a
variety of cytokines, some of which have distinct functions
(e.g., Th17 cells). Similarly, the cells might express a variety of
immunosuppressivemolecules (e.g., Tregs). The diverse effector
strain-evoked phenotypes observed in these cells might be
further modified, in a complex fashion, by numerous members
of the microbiota or in response to complex sets of interactions,
even if the initial phenotypic response measured is induced
by a smaller subset of the community. Such processes are diffi-
cult to identify with more traditional approaches. Based on the
modeling results, more targeted follow up colonizations can be
used to assess and confirm the validity of the results.
Improving the Throughput for Functional Screeningwith
‘‘Out of the Isolator’’ Gnotobiotics
A large number of individual gnotobiotic isolators would be
required to perform these experiments given the need for a sepa-
rate isolator for each group of recipientmice that receives a given
subset of the culture collection. To overcome this challenge,
we validated a simple scalable system termed ‘‘out-of-the-
isolator’’ gnotobiotics. It involves sterilization of a rayon filter-
topped cage together with enclosed bedding, food, water,
syringe, and a gavage needle. Germ-free mice, reared in a tradi-
tional gnotobiotic isolator are gavaged with bacterial subsets
of interest in a laminar flow hood and then housed in these cages
on a standard cage rack. Cross-cage contamination can be
prevented by adhering to the following practices: (1) only a single
cage should handled at any one time in the laminar flow hood, (2)
once an animal is introduced into a cage (with or without gavage
of microbes), the lid needs to be securely attached (with taping)
and all efforts made to minimize subsequent movement of the
cage for the duration of the experiment, (3) the laminar flow
hood should be sterilizedwith 70%ethanol and the experimenter
should change his/her gloves and gown after each cage is set
up, and (4) animals should be maintained in their cages in a
room under positive pressure supplied with HEPA-filtered air.
Using these procedures, over the course of a 2 week period,
>95% of animals remain free of unwanted environmental
contamination when assayed by metagenomic sequencing of
fecal DNA, essentially mimicking the situation in a traditional
gnotobiotic isolator. This means that a single gnotobiotic isolator
can be used to generate the germ-freemice required to test hun-
dreds of subsets (Faith et al., 2014)
An Example of How These Methods Have Been Used to
Identify Effector Strains that Induce Treg Cells
We recently used the approach described above to identify hu-
man gut bacterial strains capable of inducing Treg cells (Faith
et al., 2014). We generated an arrayed culture library composed
of 17 bacterial strains, isolated from the fecal microbiota of a lean
healthy female living in the USA whose complete uncultured
community promoted increases in colonic Treg cells when trans-
planted to gnotobiotic mice. To address the issue of saturation,
we randomly selected subsets of different size from the initial 17
strains, as outlined above, and administered these subsets to
germ-free recipients using the ‘‘out-of-the-isolator’’ system. By
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approximation as to whether the cultured community was
capable of saturating a response of interest and if so, what pro-
portion of community members were capable of inducing the
saturation. This allowed us to perform targeted follow-up exper-
iments with consortia sizes that produced high phenotypic vari-
ance and to avoid consortia that were larger than the phenotype
saturation point (and thus uninformative for identifying effector
strains). To our surprise, we found that colonic Treg cells satu-
rated at small community sizes (subsets with as few as one
strain), suggesting that a large proportion of the cultured compo-
nent of the donor’s microbiota was capable of inducing the
phenotype, rather than one or two specialized effector strains.
In such cases, small communities (colonization of germ-free
mice with one or two members in mono- and bicolonization
experiments) were necessary to identify the effector strains
responsible, because no phenotypic variation was observed
when larger community sizes were tested. The experimental
approach expanded our knowledge of the range of bacterial
taxa that could induce a response, prominent among them being
(genetically manipulatable) Bacteroides caccae and Bacteroides
thetaiotaomicron. We observed a favored accumulation of
Nrp1lo/ pTregs (Faith et al., 2014). Given recent demonstrations
that gut bacterial products boost pTreg cell generation in
response to orally administered nonbacterial antigens (Furusawa
et al., 2013), identifying effector strains and the mechanisms by
which they stimulate pTreg generation might provide strategies
for promoting Treg cell responses to bacterial or food-derived
antigens.
The modeling approaches we describe are valuable when a
combination of different strains is required to induce a pheno-
type of interest. Strains identified from such models can then
be added, as a consortium, to germ-free mice or to mice colo-
nized with microbes incapable of eliciting the phenotype to
confirm results from the model. Further proof of the requirement
for each member of the consortium can be obtained by perform-
ing ‘‘leave one out’’ style experiments, where all members save
one are administered to recipient animals.
Generalizing the Combinatorial Approach to Study How
the Microbiota Affects Many Features of Immunity
Metabolism represents an important but still poorly character-
ized point of intersection between the microbiota and immune
responses. For example, short chain fatty acids, bacterial end
products of fermentation, support development of an anti-in-
flammatory environment in the intestine (Arpaia et al., 2013;
Chang et al., 2014; Furusawa et al., 2013; Smith et al., 2013),
whereas generation of an arylhydrocaron receptor agonist by
Lactobacilli reuteri in the intestine can activate host-defense
pathways (Zelante et al., 2013). There is likely a plethora of immu-
nomodulatory metabolites waiting to be discovered that reflect
metabolism by individual microbes, cometabolism by members
of the microbiota, and host-microbial cometabolism. A first
step in dissecting these contributions is to identify effector
strains whose presence or absence leads to accumulation or
removal of specific metabolites. Whereas in our recent work
(Faith et al., 2014) significant modulation of colonic Treg cells
was documented in monocolonization studies, higher order
interactions were observed to determine the concentration of anumber of metabolites in the distal gut (e.g., amounts were
determined by the presence of two particular species or the
presence of one and the absence of another; Faith et al., 2014).
Documenting that the presence or absence of a metabolite
correlates with the presence or absence of particular strains
begs for follow-up mechanistic analyses that could involve
genetic or biochemical approaches, or combinations of the
two (Wieland Brown et al., 2013). Targeted depletion of metabo-
lites of interest can be challenging. For example, knowledge of
the pathways that regulate the amounts of the metabolite of
interest is required for targeted genetic interventions. Alterna-
tively, biochemical manipulation of the activities of enzymes
that control production or further chemical modification of a
metabolite of interest depends on the availability of inhibitors
(or agonists) of the enzyme. Alternatively, the fate of metabolites
can be followed with labeled compounds or their precursors, but
this approach can be costly.
Interactions between members of the microbiota and other
immune cell populations can be characterized using this
combinatorial approach, including interactions involving CD8+
T cells, B cells, gd T cells, or various components of innate
immunity. How the gut microbiota is able to shape local and
systemic T and B cell receptor repertoires remains a major
area of investigation. Experimental systems that use restricted
T cell receptor repertoires have produced varied results (Lath-
rop et al., 2011; Cebula et al., 2013) regarding the tissues that
generate antigen-specific populations of Treg cells. Modeling-
based approaches, akin to those employed to identify effector
strains that modulate cecal metabolites, could be used in
conjunction with sequenced T cell receptor and B cell receptor
repertoires in recipient mice colonized with microbial consortia
of varying size and composition to help establish which strains
are linked to particular repertoires. Used in conjunction with
more reductionist approaches, such strategies should help
address these issues. Furthermore, germ-free recipients that
have been subjected to various genetic manipulations can be
used, or environmental conditions such as diet can be system-
atically varied. The latter analysis could involve a combinatorial
approach with different diets, each containing different propor-
tions of a set of ingredients, fed in ordered sequence to individ-
ual mice colonized with a given effector bacterial strain previ-
ously shown to modulate an immune cell population in the
context of the ‘‘parental’’ (unmanipulated) diet. Feature selec-
tion can be employed to identify which component of the diet
is the principal driver of the (immune) phenotypic variation
(Faith et al., 2011). These types of defined and manipulated
gnotobiotic models can be analyzed at increasing depth and
breadth, including, for example, assaying the effects of the
interaction between different diet ingredient combinations
with the effector strain on microbial metabolism or the patterns
of gene expression and metabolism of the immune cell popula-
tion whose representation is being affected by these manipula-
tions.
Finally, it is reasonable to ask why there is a need to identify as
many strains as possible that are capable of modulating a given
immune phenotype. We believe that the reasons are 2-fold. First,
if we are to use gut microbes as a predictor of whether or not an
individual will be susceptible to immunopathology due, for
example, to a lack of Treg cell-inducing organisms, it will beImmunity 40, June 19, 2014 ª2014 Elsevier Inc. 821
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the strains then we might inaccurately predict that an individual
is at risk for intestinal inflammation. Second, although studying
an individual bacterial strain can yield important insights, charac-
terizing the response to many different strains and species
represents a starting point for identifying generalizable ‘‘rules’’
underlying the interaction rather than peculiarities of a particular
system. This is analogous to the benefit derived from studying
a single transgenic TCR and model antigen system, versus a
collection of such model systems, each with different affinities
for the antigen. The take home message is that by identifying
effector strains, the complexity of themicrobiota can be reduced
and mechanisms deciphered, while at the same time the task of
mining the microbiota for its diagnostic and therapeutic potential
can be facilitated.
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